• Co-developed offering connects Integrated DNA Technologies’ CRISPR engineering and analysis expertise with Aldevron’s mRNA manufacturing capabilities, helping customers move from discovery toward clinical development with greater speed, continuity, and confidence.
• Research grade S.p. Cas9 mRNA is available in wild type and SpyFi™ high-fidelity formats to support CRISPR-based research applications.
• Optimized mRNA constructs are designed for high on-target editing, reduced off-target activity with SpyFi, low toxicity, and delivery method flexibility.

Danaher companies Integrated DNA Technologies (IDT), a global leader in genomics, and Aldevron, a premier manufacturing partner for DNA, RNA, and protein, today announced the launch of research grade S.p. Cas9 mRNA in wild type and SpyFi™ high-fidelity formats. The new offering gives researchers and therapeutic developers access to high-quality Cas9 mRNA for CRISPR-based genome editing workflows, with performance, format flexibility, and manufacturing continuity designed to help advanced gene editing programs move from research toward development with greater confidence.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260916928591/en/